109 related articles for article (PubMed ID: 11204252)
1. A possible pathogenic role of CD8+ T cells and their derived cytokine, IL-16, in SLE.
Sekigawa I; Matsushita M; Lee S; Maeda N; Ogasawara H; Kaneko H; Iida N; Hashimoto H
Autoimmunity; 2000; 33(1):37-44. PubMed ID: 11204252
[TBL] [Abstract][Full Text] [Related]
2. Changes of CD4/CD8 ratio and interleukin-16 in systemic lupus erythematosus.
Matsushita M; Hayashi T; Ando S; Sekigawa I; Iida N; Hashimoto H; Hirose S
Clin Rheumatol; 2000; 19(4):270-4. PubMed ID: 10941806
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of CD30 on CD3 T lymphocytes in patients with systemic lupus erythematosus.
Cabrera CM; Urra JM; Carreño A; Zamorano J
Scand J Immunol; 2013 Sep; 78(3):306-12. PubMed ID: 23790231
[TBL] [Abstract][Full Text] [Related]
4. The possible role of interleukin-16 in the low incidence of HIV infection in patients with systemic lupus erythematosus.
Sekigawa I; Lee S; Kaneko H; Iida N; Hashimoto H; Hirose S; Kaneko Y
Lupus; 2000; 9(2):155-6. PubMed ID: 10787016
[No Abstract] [Full Text] [Related]
5. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
[TBL] [Abstract][Full Text] [Related]
6. Effects of 1,25(OH)
Ding Y; Liao W; He XJ; Xiang W
J Cell Mol Med; 2017 May; 21(5):975-985. PubMed ID: 28063200
[TBL] [Abstract][Full Text] [Related]
7. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares.
Amoura Z; Combadiere C; Faure S; Parizot C; Miyara M; Raphaël D; Ghillani P; Debre P; Piette JC; Gorochov G
Arthritis Rheum; 2003 Dec; 48(12):3487-96. PubMed ID: 14673999
[TBL] [Abstract][Full Text] [Related]
8. Circulating CD4+CD28null and extra-thymic CD4+CD8+ double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients.
Ugarte-Gil MF; Sánchez-Zúñiga C; Gamboa-Cárdenas RV; Aliaga-Zamudio M; Zevallos F; Tineo-Pozo G; Cucho-Venegas JM; Mosqueira-Riveros A; Medina M; Perich-Campos RA; Alfaro-Lozano JL; Rodriguez-Bellido Z; Alarcón GS; Pastor-Asurza CA
Lupus; 2016 Mar; 25(3):233-40. PubMed ID: 26385221
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities of lymphocyte subsets in canine systemic lupus erythematosus.
Chabanne L; Fournel C; Caux C; Bernaud J; Bonnefond C; Monier JC; Rigal D
Autoimmunity; 1995; 22(1):1-8. PubMed ID: 8882416
[TBL] [Abstract][Full Text] [Related]
10. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
[TBL] [Abstract][Full Text] [Related]
11. [Possible pathogenic role of IL-16 on SLE: with reference to HIV-1 infection].
Lee S; Sekigawa I
Ryumachi; 1998 Oct; 38(5):747-51. PubMed ID: 9852753
[No Abstract] [Full Text] [Related]
12. The spliceosomal autoantigen heterogeneous nuclear ribonucleoprotein A2 (hnRNP-A2) is a major T cell autoantigen in patients with systemic lupus erythematosus.
Fritsch-Stork R; Müllegger D; Skriner K; Jahn-Schmid B; Smolen JS; Steiner G
Arthritis Res Ther; 2006; 8(4):R118. PubMed ID: 16859514
[TBL] [Abstract][Full Text] [Related]
13. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
[TBL] [Abstract][Full Text] [Related]
14. Role of Stem Cell-Like Memory T Cells in Systemic Lupus Erythematosus.
Lee YJ; Park JA; Kwon H; Choi YS; Jung KC; Park SH; Lee EB
Arthritis Rheumatol; 2018 Sep; 70(9):1459-1469. PubMed ID: 29660266
[TBL] [Abstract][Full Text] [Related]
15. The suppression of murine lupus by a tolerogenic peptide involves foxp3-expressing CD8 cells that are required for the optimal induction and function of foxp3-expressing CD4 cells.
Sharabi A; Mozes E
J Immunol; 2008 Sep; 181(5):3243-51. PubMed ID: 18713995
[TBL] [Abstract][Full Text] [Related]
16. Participation of the CD69 antigen in the T-cell activation process of patients with systemic lupus erythematosus.
Crispin JC; Martínez A; de Pablo P; Velasquillo C; Alcocer-Varela J
Scand J Immunol; 1998 Aug; 48(2):196-200. PubMed ID: 9716112
[TBL] [Abstract][Full Text] [Related]
17. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.
Amel-Kashipaz MR; Huggins ML; Lanyon P; Robins A; Todd I; Powell RJ
J Autoimmun; 2001 Sep; 17(2):155-63. PubMed ID: 11591124
[TBL] [Abstract][Full Text] [Related]
18. Decreased recent thymus emigrant number is associated with disease activity in systemic lupus erythematosus.
Vieira QF; Kayser C; Kallas EG; Andrade LE
J Rheumatol; 2008 Sep; 35(9):1762-7. PubMed ID: 18634155
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of ganglioside GM1 in peripheral CD4+ T cells correlates soluble form of CD30 in Systemic Lupus Erythematosus patients.
Dong L; Hu S; Chen F; Lei X; Tu W; Yu Y; Yang L; Sun W; Yamaguchi T; Masaki Y; Umehara H
J Biomed Biotechnol; 2010; 2010():569053. PubMed ID: 20625494
[TBL] [Abstract][Full Text] [Related]
20. Aberration of CCR7 CD8 memory T cells from patients with systemic lupus erythematosus: an inducer of T helper type 2 bias of CD4 T cells.
Sen Y; Chunsong H; Baojun H; Linjie Z; Qun L; San J; Qiuping Z; Junyan L; Zhang X; Jinquan T
Immunology; 2004 Jun; 112(2):274-89. PubMed ID: 15147571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
